Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07805837) titled 'Comparative Immunologic Mechanisms and Microbiome Interactions Following Different Influenza Vaccine Formulations in Older Adults' on Sept. 1.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: None (Open Label).
Primary Sponsor: Korea University Guro Hospital
Condition:
Influenza
Influenza Vaccines
Microbiome
Immune Response
Intervention:
Biological: Standard-Dose Influenza Vaccine
Biological: MF59-Adjuvanted Influenza Vaccine
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: October 25,...